First new type of malaria treatment in decades shows promise against drug resistance
First new type of malaria treatment in decades shows promise against drug resistance Summary Novartis’s ganaplacide–lumefantrine (GanLum) produced promising clinical-trial results presented at ASTMH: it cured 97.4% of participants compared…
